Scope expansion in 2022 moved beyond chronic noncancer pain to all outpatient adults with pain, with broadened guidance on dosing, duration, tapering, discontinuation, and follow-up. State and system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results